Figure 6

Approved drugs with six or more patterns. Twelve FDA-approved drugs across very different diseases and targets (panel A). Six are nucleobases like BVDU, but six are novel scaffolds. The patterns for π-stacking (A–D) and double hydrogen bond (E–G) are present in the majority of these compounds.